Elaine Sun

Ms. Sun brings to Halozyme more than 20 years of experience in investment banking and life science industries. Ms. Sun joined Halozyme in March 2020 as Senior Vice President, Chief Financial Officer. She is responsible for the Finance, Information Technology and Site Operations organizations.

Prior to Halozyme, Ms. Sun served as Chief Financial Officer and Chief Strategy Officer for SutroVax, Inc., a private biopharmaceutical company, where she provided strategic, operational and financial leadership for the organization. Previously, Ms. Sun served as Managing Director and Head of West Coast Healthcare for Evercore Partners, a global independent investment banking advisory firm, and Managing Director at Merrill Lynch & Co., Inc.

Ms. Sun received her B.A. from Wellesley College and her M.B.A. from Harvard Business School. She is a member of the board of directors for Cirius Therapeutics.